Download Anesthesia for the Adult Patient With an Unrepaired Congenital

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Public health genomics wikipedia , lookup

Fetal origins hypothesis wikipedia , lookup

Disease wikipedia , lookup

Patient safety wikipedia , lookup

Dysprosody wikipedia , lookup

Adherence (medicine) wikipedia , lookup

Seven Countries Study wikipedia , lookup

List of medical mnemonics wikipedia , lookup

Transcript
Anesthesia for the Adult Patient With an
Unrepaired Congenital Cyanotic Heart Defect:
A Case Report
Marianne S. Cosgrove, CRNA, DNAP, APRN
Adult congenital heart disease, previously considered a
rare comorbidity, is increasingly becoming a reality for
today’s anesthesia providers. Improvements in prenatal
diagnosis, sophisticated surgical techniques and equipment, advances in pediatric critical care, enhanced
efficacy of cardiovascular pharmacologic agents, and
an overall increase in postrepair survival rates have
resulted in an estimated population of approximately
800,000 adults with congenital heart disease. Despite
successful surgical repair or palliation, these individuals present the anesthesia provider with a multitude of
challenges. Individualized care of these fragile patients
should be approached with a keen understanding of
the patient’s underlying cardiac anomaly.
This case report chronicles the anesthetic care of a
36-year-old woman presenting for left-sided uretero-
I
t is difficult to accurately estimate the actual incidence rate of congenital heart disease. This is secondary to widespread variations in the scope and severity
of its various forms. Congenital heart defects may
present as mild lesions such as minor endocardial
cushion defects or moderate to severe defects arising
from morphologic anomalies of the myocardium and
cardiac vasculature. In 2002, a meta-analysis of 44 studies attempted to ascertain a valid rate of congenital heart
disease currently. As a result of this compilation of data,
the incidence rate of moderate to severe congenital heart
disease was estimated to range from 6 to 19 per 1,000 live
births, with an overall rate of 75 per 1,000 live births.1
Congenital heart defects account for 50% of all infant
deaths and approximately 33% of all hospitalizations secondary to inborn anomalies in the United States.2
Although congenital heart disease was previously
thought to be confined to the pediatric population, the
prevalence of adult congenital heart disease (ACHD)
continues to escalate. Interventions such as improved
prenatal detection and diagnosis, advanced surgical techniques, novel medical therapies, and more efficacious
pharmaceutical agents have facilitated the expansion of
this subset of patients.3 Estimates of the prevalence of
ACHD range from 500,0004 to 800,0005 to 1.5 million6
US adults. The growth of this population is expected to
continue at a rate of 5% per year.4 It is now projected that
www.aana.com/aanajournalonline
scopy with laser lithotripsy and stent placement. Her
medical history was remarkable for the presence
of complex congenital heart disease consisting of
multiple anomalies: a double-outlet right ventricle,
transposition of the great arteries, pulmonary stenosis,
atrial septal defect, and a hypoplastic left ventricle with
concomitant mitral valve atresia.
General anesthesia was successfully administered,
with meticulous attention given to maintenance of
systemic vascular resistance to minimize shunting,
oxygenation, administration of preprocedure antibiotics, and judicious replacement of intravenous fluids
via air-filtered tubing.
Keywords: Adult, congenital heart disease, cyanotic
heart lesions, general anesthesia.
80% to 85% of patients with congenital heart disease will
survive to adulthood.7 Due to the unique needs of these
patients, there is currently a movement for a focused
specialization on care of adult patients with congenital
heart disease, as well as the development of regional
specialty centers.5,7-10 A multidisciplinary team approach
involving specialists in internal medicine, cardiology,
cardiac surgery, nursing, and social services is best suited
to the comprehensive care of the adult patient with congenital heart disease. These congenital lesions carry not
only multisystemic manifestations but also psychosocial
ramifications.11,12 With the advent of advanced medical
and surgical techniques, the possibility of caring for the
adult patient with unrepaired or palliated congenital
heart disease, albeit rare, is present nonetheless. Due
to the presence of a relatively small patient population
coupled with complex medical demands and precarious
conditions, it is alleged that adult patients with congenital heart disease may be prone to receive “suboptimal
medical management.”13
To date, there is a paucity of data regarding the anesthetic care of adult patients with unrepaired cardiac
anomalies. Few of these patients survive into adulthood
because of their serious physiological derangements.
An expansive search of the literature provides only a
few reports of patients with unrepaired cardiac lesions
undergoing anesthesia for noncardiac surgery. Because
AANA Journal

June 2012

Vol. 80, No. 3
197
the effects of anesthesia on these special patients has not
been extensively researched, specific, evidence-based
recommendations for their anesthetic care continue to
be developed.14
Case Summary
A 36-year-old, 62-kg woman presented emergently to the
operating room with a symptomatic, 1-cm, distal left-sided ureterolithiasis. Her medical history was remarkable
for complex congenital heart disease consisting of transposition of the great arteries, double-outlet right ventricle
(RV), pulmonary stenosis without substantial pulmonary
hypertension, atrial septal defect (ASD), and hypoplastic
left heart syndrome (HLHS) with mitral atresia. She had
been palliated with a balloon atrial septostomy at age 8
years, but the major constituents of her anomalies remained unrepaired. Additional surgical history included
a cleft lip and palate repair at age 1 year and a cardiac
ablation for chronic atrial flutter at age 28 years. She
reported no untoward reactions to general anesthesia.
Five years before her present admission, a symptomatic
ureterolithiasis had been managed conservatively with
intravenous (IV) hydration and analgesics. However,
fulminant congestive heart failure quickly developed
because of excessive fluid administration. Because of this
history and the fact that the patient was experiencing
severe discomfort, immediate surgical intervention with
ureteroscopy, laser lithotripsy, and stent placement in
the left ureter was indicated.
Preoperatively, the patient’s cardiologist was contacted by phone, and she verified that she had found
the patient to be in stable condition 1 week before this
hospitalization. After consultation between the urologic
surgeon, the anesthesiologist, the Certified Registered
Nurse Anesthetist (CRNA), the patient, and her father, it
was decided to proceed with surgery under general endotracheal anesthesia. Spinal anesthesia was not considered
as an option because of the potential for a precipitous
drop in systemic vascular resistance (SVR), leading to an
increase in right-to-left shunting, as well as because of
the patient’s apprehension regarding the procedure.
The patient’s medical history was also notable for
hypothyroidism and ventricular fibrillation and cardiac
arrest at age 29 years, with sequelae of residual, mild
neurologic deficit and long-term oxygen dependence.
As a result, she received continuous oxygen therapy via
nasal cannula at 4 L /min. She had an allergy to sulfa
medications and a self-reported untoward reaction to
epinephrine with a chief complaint of “rapid heart rate.”
Her medication profile included amiodarone, 200 mg
twice a day; digoxin, 0.125 mg 5 times a week; enalapril,
5 mg every day; ferrous sulfate, 325 mg every day; levothyroxine, 12.5 µg/d; and acetylsalicylic acid, 81 mg/d.
Preoperative laboratory values were notable for a total
white blood cell count of 18.1 × 1,000/µL (4.0-10.0 ×
198
AANA Journal

June 2012

Vol. 80, No. 3
1,000/µL), differential neutrophils of 83% (38%-81%),
differential lymphocytes of 7% (14%-46%), hematocrit
of 45.2%, mean corpuscular volume of 96 fL (78-94
fL), creatinine of 1.3 mg/dL (0.6-1.2 mg/dL), aspartate
aminotransferase of 43 U/L (0-35 U/L), bilirubin of 0.21
mg/dL (< 0.2 mg/dL), and 2+ proteinuria. Electrolytes,
glucose, serum urea nitrogen, platelets, and international
normalized ratio values were within normal limits.
The preoperative electrocardiogram revealed a left
anterior hemiblock, right bundle branch block, left atrial
enlargement, and left axis deviation. Auscultation of
the precordium was remarkable for a loud holosystolic
murmur. Chest radiograph was notable for cardiomegaly
with enlarged pulmonary arteries centrally but with no
active pulmonary disease. Her baseline vital signs were
temperature, 36.4°C; pulse, 61 to 70/min; BP, 114 to
137/69 to 71 mm Hg; and arterial oxygen saturation
(Sao2), 88% to 89% on 4 L of oxygen administered via
nasal cannula. Her airway was remarkable for the presence of a palatal obturator. She was classified with a
Mallampati II score with good oral aperture, thyromental
distance, and cervical range of motion. She reported a
pain scale of 7 of 10 and had received morphine sulfate,
2 mg IV × 2, in the emergency department before being
transferred to the operating room.
The patient was brought into the cystoscopy suite via
stretcher. A 20-gauge IV catheter was inserted in her right
wrist, and an infusion of lactated Ringer’s solution was
initiated via a microdrip set. The IV tubing and stopcocks
had been meticulously examined for the presence of air
bubbles and subsequently de-aired. An inline air filter
was added to the tubing, and all bolus IV medications
were administered through it. Antibiotic prophylaxis
was achieved with the slow IV administration of ampicillin, 2 g, and gentamicin, 80 mg, before commencement
of the anesthetic induction and airway manipulation.
Standard monitors were applied, and denitrogenation
was achieved to an end-tidal nitrogen concentration of
< 5% via sealed face mask. Oxygen saturation increased
from baseline values to 98%. An end-tidal carbon dioxide
(etco2) concentration was obtained before anesthetic
induction. It was noted to be lower than expected at 25
mm Hg due to the presence of the cyanotic lesion. Initial
IV sedation consisted of midazolam, 1 mg, and fentanyl,
40 µg. Induction of anesthesia and muscle relaxation was
achieved with ketamine, 60 mg IV, and rocuronium, 35
mg IV; the patient was mask ventilated before laryngoscopy, and the airway was found to be patent. She was
intubated with ease on the first attempt with a 6.0-mm
internal-diameter endotracheal tube. The smaller endotracheal tube was chosen because of the presence of a
visibly small glottic aperture. Breath sounds were equal
and clear to auscultation bilaterally. A modest increase in
HR from 70/min to 81/min was noted with laryngoscopy
and intubation; this resolved over the next 10 minutes
www.aana.com/aanajournalonline
without intervention and continued at baseline values for
the remainder of the procedure.
Immediately after anesthetic induction, an arterial line
was placed in the patient’s right radial artery to facilitate
continuous monitoring of blood pressure (BP). The
patient was placed in the lithotomy position. Anesthesia
was maintained with 1% to 3% of sevoflurane and an
inspired oxygen concentration (Fio2) of 0.97 to 1.0. The
volatile agent was titrated according to BP and bispectral
index values. A second dose of fentanyl, 20 µg IV, was
administered during the course of the anesthetic, as well
as 4 mg IV of ondansetron, as prophylaxis against the
development of postoperative nausea and vomiting.
Vital signs remained stable throughout the course of
the case, with BP ranging from 105 to 145/42 to 60 mm
Hg; HR, 52/min to 81/min; Sao2, 94% to 98%; etco2, 31
to 40 mm Hg, and bispectral index, 51 to 58. The surgery
proceeded without incident and was concluded within
45 minutes. Removal of the ureteral calculi was achieved
with the use of a basket and was followed with left ureteral stent placement. Estimated blood loss was minimal,
and total IV fluids were 400 mL: 200 mL of maintenance
fluids and 200 mL for antibiotic administration. Residual
neuromuscular blockade was reversed with the slow administration of neostigmine, 2 mg, and glycopyrrolate,
0.4 mg IV. No apparent change in heart rate was appreciated subsequent to the administration of these agents.
Emergence from anesthesia was smooth, and the patient
was extubated awake after responding appropriately to
commands.
The patient was transported to the postanesthesia
care unit (PACU) and given 4 L/min of oxygen via nasal
cannula in stable condition. Initial vital signs in the
PACU were BP of 150/50 mm Hg, pulse rate of 60/min,
and Sao2 of 88%. Administration of IV fluids continued
at a slow rate until ice chips and fluids were tolerated
by mouth. The IV was discontinued after an additional
200 mL had infused. Total IV fluids for the surgery and
recovery period were 600 mL. Vital signs remained stable
throughout her anesthetic recovery, and the patient
offered no complaints of discomfort or nausea.
After consultation with the surgeon, the anesthesiologist, the patient, and her father, it was concluded
that she was in stable condition, and she was cleared
for discharge. This decision was motivated both by
the surgeon’s wish to circumvent the possibility of the
patient contracting a nosocomial infection as well as the
patient’s and her family’s strong desire to return home
as quickly as was feasible. The patient was discharged
to home in stable condition approximately 3 hours after
her admission to the PACU. A postoperative follow-up
call was made 24 hours after discharge by a same-day
surgery PACU nurse, who found the patient to be free of
complaints and reportedly feeling “back to normal.” No
apparent surgical or anesthetic sequelae were noted.
www.aana.com/aanajournalonline
Discussion
A review of the literature yields several case reports of
adults with unrepaired congenital heart disease undergoing anesthesia for noncardiac surgery. One account describes the anesthetic care of a 24-year-old female patient
with unrepaired tetralogy of Fallot undergoing laparoscopic cholecystectomy for pancreatitis.15 Although
previously palliated with a modified Blalock-Taussig
(right subclavian to right pulmonary artery) shunt, her
tetralogy of Fallot remained unrepaired in terms of the
essential components. A different case study reviews
the successful anesthetic management of a 22-year-old
woman undergoing appendectomy. She suffered from
situs solitus, a severe cyanotic heart defect consisting of pulmonary atresia, overriding aorta, concordant
atrioventricular shunts, aortopulmonary collateral circulation, and a large ventricular septal defect (VSD).16
Both a 22-year old man who received anesthesia for a
repeated craniotomy to repair a chronic brain abscess
and a 50-year-old woman anesthetized for emergency
laparotomy presented with complex cyanotic congenital
heart disease, further complicated by the presence of
Eisenmenger syndrome.17,18 Eisenmenger syndrome, a
severe pulmonary vascular disease, is the result of the
longstanding communication between the pulmonary
and systemic circulations. Chronic pulmonary vascular
congestion occurs from substantial left-to-right shunting through an ASD or VSD. This results in the eventual
production of pulmonary hypertension. As pulmonary
hypertension increases, shunting ultimately reverses to
a right-to-left direction, thereby causing cyanosis.14,19-21
Common denominators in all aforementioned accounts were anesthetic plans that highlighted similar
interventions: maintenance of intravascular volume
and preload and avoidance of precursors to acidosis
such as hypothermia, hypercarbia, and hypotension.
Minimization of intracardiac shunting was typically
achieved via avoidance of decreases in systemic vascular
resistance and increases in pulmonary vascular resistance
(PVR). All reported anesthetics were delivered successfully without evidence of anesthetic sequelae.
In an effort to comprehend the magnitude and physiologic implications of this patient’s structural cardiac
defects, it is essential to understand and compare them
with normal cardiac anatomy (Figure, left).
The first of the major anomalies present was transposition of the great arteries. Simple transposition is the
most common cyanotic abnormality in the newborn.5
Major findings associated with this defect include an
aorta emanating directly from the RV and a pulmonary
artery that arises from the left ventricle.5,19,22,23 Because
of the complete separation of the pulmonary and systemic circulations, mixing of the 2 is wholly dependent
on the presence of 1 or more communicating intracardiac
shunts,19 such as patent ductus arteriosus or ASD. Atrial
AANA Journal

June 2012

Vol. 80, No. 3
199
Figure. Comparison Schematics of Normal Cardiac Anatomy (left) With Patient-Specific Anomalies (right)
Abbreviations: IVC, inferior vena cava; SVC, superior vena cava; RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle;
ASD, atrial septal defect.
(Adapted from Koenig et al,22 with permission.)
septal defects may be enlarged via a balloon atrial (also
known as Rashkind) septostomy. This procedure, which
the patient had undergone as an 8-year-old, is most frequently performed with the goal of facilitating systemic
oxygenation in patients with cyanotic congenital heart
disease.24
It is interesting to note that transposition of the great
arteries may frequently accompany double-outlet RV,25
an additional lesion affecting this patient. Double-outlet
RV is a defect in which the great vessels arise either predominantly or entirely from the RV.4,25,26 The RV may
or may not be septated. Tricuspid regurgitation may also
be present.26 Additionally, double-outlet RV is always
associated with the presence of a VSD27; however, this
particular feature was absent in this patient primarily due
to the presence of HLHS.
Concomitant HLHS with mitral atresia contributed
appreciably to this patient’s complex heart defect. With
an incidence rate of 1.5 to 2 per 10,000 live births, HLHS
represents the most common left-sided obstructive heart
disease presenting in newborns. The heralding feature is
mitral valve stenosis or complete atresia in concert with
a severely underdeveloped left ventricle.28
In this patient, the combination of these anomalies essentially resulted in the presence of a 3-chambered heart,
constituting a cyanotic lesion (Figure, right). Surgical
correction of the transposition of the great arteries was
200
AANA Journal

June 2012

Vol. 80, No. 3
not compulsory secondary to the existence of a single
ventricle because mixing of pulmonary and systemic circulations was facilitated by the atrial septostomy. It was
postulated that this patient’s systemic perfusion pressures
and oxygen saturation remained relatively stable because
of the preferential shunting of oxygenated blood past the
absent mitral valve, across the large ASD, into the right
atrium through the tricuspid valve, into the dilated RV,
through the aortic valve, and into the aorta. Perfusion
was also present through the stenotic pulmonary valve,
presumably to lesser degree than the aortic valve.
Collectively with the mixing of oxygenated and deoxygenated blood, pulmonary stenosis shared a role in
the production of cyanosis that was clearly evident in
this patient. This stenosis may actually have played a
“protective” role in that, despite the fact that pulmonary
hypertension and Eisenmenger syndrome are frequently
associated with ACHD as a result of chronic pulmonary vascular congestion,21 it was largely absent in this
patient. It was the opinion of her cardiologist that this
particular factor was probably most instrumental in her
continued ability to function despite her array of major
structural cardiac defects.
The RV has a tremendous capacity to adapt to volume
and pressure demands. Although functionally of less
importance than the left ventricle, in rare instances such
as this, the RV may be responsible for both pulmonic
www.aana.com/aanajournalonline
and systemic perfusion.29 Symptoms of cardiac failure
develop after RV dysfunction is present; this, in turn, is
associated with major decreases in cardiac output and
considerable morbidity and mortality.30 Moreover, due
to the anatomical changes present with right-ventricular
hypertrophy magnified by double-outlet RV syndrome,
physical derangement or malposition of the atrioventricular node and His-Purkinje fibers are often noted.25 This
morphologic alteration of the right side of the heart is a
causative factor in these patients’ propensity to arrhythmias, most frequently supraventricular arrhythmias such
as atrial flutter and fibrillation.13,31 Supraventricular
arrhythmias are noted to exist more frequently in the
following populations: patients with complex congenital heart disease, those whose functional defects have
not been repaired, and those with chronic cyanosis.
Additionally, the incidence of supraventricular arrhythmias is directly proportional to the age of the adult
patient with congenital heart disease.31 Bundle branch
blocks and lethal ventricular arrhythmias are common in
patients with right-sided heart disease. The presence of a
single ventricle is acknowledged to predispose the patient
with congenital heart disease to a significantly greater
incidence of cardiac standstill and sudden death.29,32 The
patient in this case report had suffered a cardiac arrest at
the age of 29 years, but no ectopy had been noted during
her intraoperative or postoperative course.
Chronic cyanosis produces a specific array of physiologic effects, many of which were noted in this patient.
Derangements of the hematologic system may include
polycythemia, erythrocytosis, and attendant hyperviscosity as a result of the increased production of erythropoietin
from chronic tissue hypoxia.4,14 Thromboembolic events
are common, and IV hydration to decrease viscosity must
be carefully administered to circumvent fluid overload
and eventual congestive heart failure. Patients are prone
to both procoagulation and anticoagulation abnormalities. These may develop in the presence of hepatomegaly
and splenomegaly resulting from chronic vascular congestion.4,7,32,33 Thrombocytopenia and decreases in von
Willebrand factor, factor V, and vitamin K–dependent
factors may all be present in the cyanotic adult patient
with congenital heart disease.14 Portal hypertension from
hepatomegaly may induce a neurohormonal activation;
this causes a retention of intravascular volume and the
development of third spacing and exacerbation of edema.6
Hyperuricemia is frequently present and may develop as
a result of uric acid overproduction and reduced clearance. Hyperuricemia predisposes the cyanotic patient to
the development of nephrolithiasis, ureterolithiasis (as
was noted in this patient), and gouty arthritis.4,14,34 The
patient also exhibited proteinuria, which may be noted as
a result of increased renal vessel pressure and congestion.
Vessel proliferation throughout the body is the result of
chronic cyanosis and increases in arteriolar wall stress.
www.aana.com/aanajournalonline
Attendant with hyperviscosity, both of these attributes
stimulate the release of prostaglandins and nitric oxide,
causing arteriolar dilation and eventual vascular congestion.14 Overall vessel engorgement is further mitigated
by high central venous pressures. The summative effect
of these factors place the cyanotic patient at high risk for
the development of intraoperative bleeding14,34 Primary
side effects of this bleeding diathesis may range from mild
symptoms such as hemoptysis and oozing from line insertion sites, to severe complications such as pulmonary or
cerebral hemorrhage or both.4
To date, there is no conclusive anesthetic plan
that may be offered in the care of these patients.14,34
Preoperatively, an understanding of the patient’s underlying pathophysiology, coupled with knowledge of the
effects of anesthesia on the anomalous myocardium, is
crucial. Although extensive preoperative evaluations by
the patient’s internist, cardiologist, and cardiac surgeon
are preferable, they may not be readily available, as was
the case with this patient. Careful review of the patient’s
preoperative medication profile, with attention to potential anesthetic interactions, must be considered.
Bacterial endocarditis has posed a major concern
for the patient with congenital heart disease; however,
antibiotic prophylaxis has not been proved to prevent
this occurrence and is currently recommended for use
only in unrepaired or cyanotic forms of congenital heart
disease.14,34 Because of the tendency of the patient with
ACHD toward endocarditis, sterile technique during all
invasive procedures should be ensured.15 Airway anomalies have been associated with certain forms of congenital
heart disease35; intubation of these patients may prove to
be difficult, and preparation for this is encouraged. An
inhalation induction with sevoflurane may be suitable
for the adult with congenital heart disease, as it produces
little direct myocardial depression. Additionally, sevoflurane is devoid of unwanted sympathomimetic effects or
airway irritation, as is noted with the use of higher concentrations of desflurane.36 However, inhalation induction of anesthesia may be prolonged in the presence of
pulmonary stenosis or right-to-left shunting. Conversely,
IV induction of anesthesia may be prolonged in the presence of left-to-right shunting.36
Ketamine has gained popularity for the IV induction
of anesthesia because of its preservation of SVR and its
bronchodilatory effect,37 and it was chosen for the IV induction of anesthesia in this patient. The use of ketamine
for the induction of anesthesia “is considered one of the
safest induction techniques for the cyanotic patient.”36
The combined effects of this agent are presumed to decrease the occurrence of right-to-left shunting during
the induction phase of anesthesia. However, ketamine
has been shown to exhibit direct myocardial depressant
effects in the patient with a compromised myocardium.38
Etomidate, well known for its maintenance of cardiovas-
AANA Journal

June 2012

Vol. 80, No. 3
201
cular stability, may be used for the induction of anesthesia, yet transient adrenocortical suppression following
its use may contribute to the patient’s instability well
into the postoperative period.37,38 Opioids such as fentanyl and sufentanil offer substantial cardiac stability and
blunt the neuroendocrine response to surgical stress.37,38
Nevertheless, their overuse may lead to hypoventilation
and concomitant untoward effects due to hypoxemia
and hypercarbia,14,34 particularly in the postoperative
period. This, in turn, may ultimately lead to an increase
in PVR and the onset of right-to-left shunting. Muscle
relaxants such as vecuronium and rocuronium have high
autonomic margins of safety,37,38 but their reversal with
anticholinesterase-anticholinergic combinations should
be undertaken with care in an effort to avoid both arrhythmias and bradycardia.38
With regard to the volatile anesthetic agents, it is
known that they have little overall effect on PVR.37
However, the use of nitrous oxide (N2O) has been shown
to increase PVR.15,37 Therefore, this agent was avoided in
this patient. Additionally, due to its soluble nature, N2O
may rapidly expand air bubbles, which may be inadvertently infused IV or entrained via the surgical site. These
emboli represent a major concern in the adult patient with
congenital heart disease, especially for those with rightto-left shunts, as the occurrence of a cerebral embolic
event may have devastating consequences.39 Care must
be taken with the preparation of all IV tubing and during
the injection of IV medications; air filters should be used
for both. Transesophageal echocardiography may be used
intraoperatively to assess overall cardiac function, fluid
status, and the presence of air emboli.17 Vasodilators
as well as high concentrations of volatile anesthetics
may exacerbate cyanosis by drastically decreasing SVR,
thereby accentuating intracardiac shunting,15 particularly in single-ventricle patients.13 Phenylephrine may
be used to reverse intraoperative hypotension. Increases
in SVR from direct α-stimulation and vasoconstriction
will diminish the occurrence of right-to-left shunting.36
Cardiotonic agents such as epinephrine and isoproterenol along with anticholinergics such as atropine may
be employed in instances of attenuated cardiac output or
standstill. However, the avoidance of tachydysrhythmias
resulting from the use of these agents is of great importance. Maintenance of normothermia is also critical, as
hypothermia and shivering greatly increase oxygen consumption and the demand on the myocardium. Sustained
hypothermia may lead to decreased tissue perfusion via
vasoconstriction, acidosis, and an increased PVR, which
favors the development of right-to-left shunting.14
Intraoperatively, vigilant monitoring of the patient
with cyanotic heart lesions is essential. Continuous
measurement of arterial BP may be achieved through the
insertion of an arterial catheter. The assessment of central
venous pressure may also be useful in monitoring intra-
202
AANA Journal

June 2012

Vol. 80, No. 3
vascular fluid status. Concentrations of etco2 may be
inaccurate; lower-than-actual values may be noted in the
presence of increased right-to-left shunting. Decreases
in Sao2 may signify increased right-to-left shunting produced by increasing PVR.14,34 Increases in PVR ultimately
cause an aggravation of cyanosis and should be avoided at
all costs. Increased PVR may occur from myriad factors,
specifically hypoxia, hypercapnia, elevated airway pressures, respiratory and metabolic acidosis, and hypothermia.36,38 Overzealous manipulation of the airway may
lead to bronchospasm; this may also contribute toward
the development of increased PVR. Pulmonary hypertensive crisis resulting from increases in transthoracic
pressures may lead to acute right heart failure and result
in a major decrease in cardiac output,14,34 particularly in
patients with single-ventricle disease. The susceptibility
of patients with ACHD toward the development of pulmonary hypertension and congestive heart failure from
considerable increases in PVR poses a real concern for
the anesthesia provider. Pulmonary hypertensive crisis
constitutes a major risk for adult patients with congenital
heart disease, predisposing them to a significantly increased incidence of perioperative morbidity and mortality.14,34 Suggested modalities for the treatment of this
occurrence are hyperventilation with an inspired oxygen
concentration (Fio2) of 1.0, judicious administration
of volume, use of vasoconstrictors to elevate SVR, and
control of wide variations of the heart rate.14,34,36
Conclusion
Adult patients with congenital heart disease present
the anesthetist with unique and varied challenges.
Individualized care of these fragile patients should be
approached with a keen understanding of the patient’s
underlying cardiac anomaly, a focus on the preservation
of oxygenation, and minimization of intracardiac shunting through careful pharmacologic manipulation of the
circulation. Cautious administration of sedatives and
anesthetic agents, control of wide variations in heart rate,
avoidance of volume overload and subsequent congestive
heart failure, and avoidance of IV air embolization is also
recommended. Although previously rarely encountered
in daily practice, ACHD will likely become more prevalent in the surgical population. With careful planning by
the surgical and anesthesia care team, adult patients with
congenital heart disease may be successfully anesthetized
for noncardiac surgery without incident.
REFERENCES
1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am
Coll Cardiol. 2002; 39(12):1890-1900.
2.Boulet SL, Grosse SD, Riehle-Colarusso T, Correa-Villaseñor A.
Health care costs of congenital heart defects. In: Wyszynski DF,
Correa-Villaseñor A, Graham TP, eds. Congenital Heart Defects: From
Origin to Treatment. New York, NY: Oxford University Press; 2010:493.
3. Connor JA, Jenkins KJ. Factors associated with increased resource
utilization for congenital heart disease. In: Wyszynski DF, Correa-
www.aana.com/aanajournalonline
Villaseñor A, Graham TP, eds. Congenital Heart Defects: From Origin to
Treatment. New York, NY: Oxford University Press; 2010:481.
4. Perloff JK, Child JS, Aboulhosn J, eds. Congenital Heart Disease in
Adults. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2009:16,4546,89,265-286.
5. Warnes CA. The adult with congenital heart disease: born to be bad?
J Am Coll Cardiol. 2005;46:(1):1-8.
6.Wu FM, Landzberg MJ. Congenital heart defects in adults. In:
Wyszynski DF, Correa-Villaseñor A, Graham TP, eds. Congenital
Heart Defects: From Origin to Treatment. New York, NY: Oxford University Press; 2010:296,304.
7. British Cardiac Society Working Party. Grown-up congenital heart
(GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK. Heart.
2002;88(suppl 1):i11-i14.
8. Brown ML, Dearani JA, Burkhart HM. The adult with congenital heart
disease: medical and surgical considerations for management. Curr
Opin Pediatr. 2009;21(5):561-564.
9. Chessa M, Cullen S, Deanfield J, et al. The care of adult patients with
congenital heart defects: a new challenge. Ital Heart J. 2004;5(3):178182.
10. Dearani JA, Connolly HM, Martinez R, Fontanet H, Webb GD. Caring
for adults with congenital cardiac disease: successes and challenges
for 2007 and beyond. Cardiol Young. 2007;17(suppl 2):87-96.
11. Foster E, Graham TP Jr, Driscoll DJ, et al. Task force 2: special health
care needs of adults with congenital heart disease. J Am Coll Cardiol.
2001;37(5):1176-1183.
12. Reid GJ, Kovacs AH. Psychological aspects of adults with complex
congenital heart defects. In: Wyszynski DF, Correa-Villaseñor A,
Graham TP, eds. Congenital Heart Defects: From Origin to Treatment.
New York, NY: Oxford University Press; 2010:356.
13. Somerville J. Management of adults with congenital heart disease: an
increasing problem. Annu Rev Med. 1997;48:283-293.
14. Cannesson M, Earing MG, Collange V, Kersten JR. Anesthesia for
noncardiac surgery in adults with congenital heart disease. Anesthesiology. 2009;111(2):432-440.
15. Andrews JD. Laparoscopic cholecystectomy for the adult with unrepaired tetralogy of Fallot: a case report. AANA J. 1999;67(1):67-71.
16. Chatzidaki R, Koraki E, Vasiliadis K, Aslanidis T, Vasilakos D. Appendectomy for an adult with cyanotic congenital heart disease. Minerva
Anestesiol. 2009;75(4):225-228.
17. Asamoto M, Kitamura T, Ohno N, et al. Anesthetic management for
emergency laparotomy in an adult patient with Eisenmenger syndrome: a case report [abstract, Japanese]. Masui. 2009;58(8):10211024.
18. Kakemizu M, Sakai H, Suzuki K, Okazaki A. Anesthetic management
of craniotomy for a young adult patient with congenital cyanotic heart
disease [abstract, Japanese]. Masui. 2010;59(2):202-205.
19. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults:
second of two parts [published correction appears in: N Engl J Med.
2000;342(13):988]. N Engl J Med. 2000;342(5):334-342.
20. Cannobio MM, Chuch R. Pregnancy and congenital heart disease.
In: Wyszynski DF, Correa-Villaseñor A, Graham TP, eds. Congenital
Heart Defects: From Origin to Treatment. New York, NY: Oxford University Press; 2010:318.
21. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with
congenital heart disease. Circulation. 2007;115(8):1039-1050.
22. Koenig P, Hijazi Z, Zimmerman F. Essential Pediatric Cardiology. New
York, NY; McGraw-Hill; 2004:138,156,195,227,261.
23. Rouine-Rapp K. Anesthesia for transposition of the great vessels. In:
Andropoulos DB, Stayer SA, Russell IA, Mossad EB. Anesthesia for
www.aana.com/aanajournalonline
Congenital Heart Disease. 2nd ed. West Sussex, UK: Wiley-Blackwell;
2010:444-445.
24. Mukherjee D, Lindsay M, Zhang Y, et al. Analysis of 8681 neonates
with transposition of the great arteries: outcomes with and without
Rashkind balloon atrial septostomy. Cardiol Young. 2010:20(4):373380. http://journals.cambridge.org/action/displayFulltext?type=6&fi
d=7820788&jid=CTY&volumeId=20&issueId=04&aid=7820787&
bodyId=&membershipNumber=&societyETOCSession=&fulltextT
ype=RA&fileId=S1047951110000296. Published May 17, 2010.
Accessed May 27, 2010.
25.Horenstein MS, Epstein ML. Double outlet right ventricle, with
transposition. 2008. http://emedicine.medscape.com/article/896082.
Accessed May 27, 2010.
26. Parrish MD, Moon-Grady AJ, Meadows J. Right ventricular outflow
tract obstruction. In: Wyszynski DF, Correa-Villaseñor A, Graham
TP, eds. Congenital Heart Defects: From Origin to Treatment. New York,
NY: Oxford University Press; 2010:211.
27. Castaneda AR, Jonas RA, Mayer JE Jr, Hanley FL. Cardiac Surgery of
the Neonate and Infant. Philadelphia, PA: WB Saunders Co; 1994:415416.
28. Lake CL, Booker PD. Pediatric Cardiac Anesthesia. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:357-364,445.
29. Warnes CA. Adult congenital heart disease and the importance of the
right ventricle. J Am Coll Cardiol. 2009;54(21):1903-1910.
30. Davlouros PA, Niwa K, Webb G, Gatzoulis MA. The right ventricle in
congenital heart disease. Heart. 2006;92(suppl 1):i27-i38.
31. Trojnarska O, Grajek S, Kramer L, Gwizdala A. Risk factors of supraventricular arrhythmia in adults with congenital heart disease. Cardiol
J. 2009;16(3):218-226.
32. Steven JM. Congenital heart disease and anesthesia-related cardiac
arrest: connecting the dots. Anesth Analg. 2010;110(5):1255-1256.
33. Iserin L. Cyanotic heart disease in the adult [French]. Arch Mal Coeur
Vaiss. 2002;95(11):1100-1103.
34. Cannesson M, Collange V, Lehot JJ. Anesthesia in adult patients with
congenital heart disease. Curr Opin Anaesthiol. 2009;22(1):88-94.
35.Mossad EB, Joglar J. Preoperative evaluation and preparation. In:
Andropoulos DB, Stayer SA, Russell I, Mossad EB, eds. Anesthesia for
Congenital Heart Disease. 2nd ed. West Sussex, UK: Wiley-Blackwell;
2010:228.
36. Levin SK, Arslan-Carlon V. Tetralogy of Fallot. In: Yao FSF, ed. Yao &
Artusio’s Anesthesiology: Problem-Oriented Patient Management. 5th ed.
Philadelphia, PA: Lippincott Williams & Wilkins; 2003:242-244.
37.Stoelting RK, Hillier SC. Pharmacology and Physiology in Anesthetic
Practice. 4th ed. Philadephia, PA: Lippincott Williams & Wilkins;
2006:54,106-110,165-166,172,233,235,238.
38. Andropoulos DB. Anesthetic agents and their cardiovascular effects.
In: Andropoulos DB, Stayer SA, Russell I, Mossad EB, eds. Anesthesia
for Congenital Heart Disease. 2nd ed. West Sussex, UK: Wiley-Blackwell; 2010:80,83,85,89.
39. Reddy VM, Hanley FL, Boltz MG, Ramamoorthy C. Pediatric cardiovascular surgery. In: Jaffe RA, Samuels SI, eds. Anesthesiologist’s
Manual of Surgical Procedures. 4th ed. Philadephia, PA: Lippincott
Williams & Wilkins; 2009:1201.
AUTHOR
Marianne S. Cosgrove, CRNA, DNAP, APRN, is the assistant program
director at the Hospital of St Raphael School of Nurse Anesthesia, New
Haven, Connecticut; a staff CRNA at the Hospital of St Raphael and
Yale-New Haven Hospital, New Haven, Connecticut; and co-owner of
and lecturer for Core Concepts Anesthesia Review LLC. Email: marianne.
[email protected].
AANA Journal

June 2012

Vol. 80, No. 3
203